Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Direct Meds
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Direct Meds: October 2026
vs
Verdict82/ 100
Grade B− · #29Direct Meds
One of the rare programs offering a sublingual route on both molecules with all-inclusive pricing and a nurse team to call — but a 90-day supply ships at once, and its prices have climbed well above what it once advertised.
Visit Direct MedsThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 82/100 (grade A vs B−). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Direct Meds still earns its place — needle-averse patients who specifically want a sublingual GLP-1 option and are willing to vet a newer operator themselves.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results80
92
Real-world results80
97Price honesty82
97
Price honesty82
96Prescriber access80
96
Prescriber access80
88Formulary choice88
88
Formulary choice88
95Cancellation fairness82
95
Cancellation fairness82
93Member support80
93
Member support80
Price, coverage & features
| Metric | CoreAge Rx | Direct Meds |
|---|---|---|
| Verdict Score | 94/100 | 82/100 |
| Grade | A | B− |
| Semaglutide | $99/mo | From $249/mo sublingual, $297/mo injectable (90-day supply, billed monthly) |
| Tirzepatide | $149/mo | From $299/mo sublingual, $399/mo injectable (90-day supply, billed monthly) |
| Coverage | All 50 states | 48 states (not Mississippi or Louisiana) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Direct Meds
What we like
- Rare sublingual drops on both molecules — semaglutide from $249/mo and tirzepatide from $299/mo — plus an injectable path
- All-inclusive pricing with no separate membership fee to layer on top
- Covers both semaglutide and tirzepatide rather than a single molecule
The caveats
- Every option is compounded, not FDA-approved
- A 90-day supply ships at once and is billed monthly, so you hold three months of medication from the start
- Newer entity (est. 2024) operating across several similar-looking domains, so confirm you're on the right one
- Not available in Mississippi or Louisiana
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Needle-averse patients who specifically want a sublingual GLP-1 option and are willing to vet a newer operator themselves.
Visit Direct Meds Read the full Direct Meds review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Direct Meds does the reverse.
More on CoreAge Rx
More on Direct Meds
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.